Cargando…
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs
BACKGROUND: Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs Needle syringe programmes (NSP) and opioid substitution therapy (OST) are the primary interventions to reduce hepatitis C (HCV) transmission in people who inject d...
Autores principales: | Platt, Lucy, Minozzi, Silvia, Reed, Jennifer, Vickerman, Peter, Hagan, Holly, French, Clare, Jordan, Ashly, Degenhardt, Louisa, Hope, Vivian, Hutchinson, Sharon, Maher, Lisa, Palmateer, Norah, Taylor, Avril, Bruneau, Julie, Hickman, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621373/ https://www.ncbi.nlm.nih.gov/pubmed/28922449 http://dx.doi.org/10.1002/14651858.CD012021.pub2 |
Ejemplares similares
-
Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta‐analysis
por: Platt, Lucy, et al.
Publicado: (2017) -
The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review
por: Gillies, Michelle, et al.
Publicado: (2010) -
Impact of current and scaled‐up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings—what is required to achieve the WHO's HCV elimination targets?
por: Ward, Zoe, et al.
Publicado: (2018) -
Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis
por: MacArthur, Georgie J, et al.
Publicado: (2012) -
The impact of COVID-19 restrictions on needle and syringe programme provision and coverage in England
por: Whitfield, Mark, et al.
Publicado: (2020)